Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies
- PMID: 23221879
- PMCID: PMC3525817
- DOI: 10.1093/jnci/djs461
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies
Abstract
Background: Carotenoids, micronutrients in fruits and vegetables, may reduce breast cancer risk. Most, but not all, past studies of circulating carotenoids and breast cancer have found an inverse association with at least one carotenoid, although the specific carotenoid has varied across studies.
Methods: We conducted a pooled analysis of eight cohort studies comprising more than 80% of the world's published prospective data on plasma or serum carotenoids and breast cancer, including 3055 case subjects and 3956 matched control subjects. To account for laboratory differences and examine population differences across studies, we recalibrated participant carotenoid levels to a common standard by reassaying 20 plasma or serum samples from each cohort together at the same laboratory. Using conditional logistic regression, adjusting for several breast cancer risk factors, we calculated relative risks (RRs) and 95% confidence intervals (CIs) using quintiles defined among the control subjects from all studies. All P values are two-sided.
Results: Statistically significant inverse associations with breast cancer were observed for α-carotene (top vs bottom quintile RR = 0.87, 95% CI = 0.71 to 1.05, P(trend) = .04), β-carotene (RR = 0.83, 95% CI = 0.70 to 0.98, P(trend) = .02), lutein+zeaxanthin (RR = 0.84, 95% CI = 0.70 to 1.01, P(trend) = .05), lycopene (RR = 0.78, 95% CI = 0.62 to 0.99, P(trend) = .02), and total carotenoids (RR = 0.81, 95% CI = 0.68 to 0.96, P(trend) = .01). β-Cryptoxanthin was not statistically significantly associated with risk. Tests for heterogeneity across studies were not statistically significant. For several carotenoids, associations appeared stronger for estrogen receptor negative (ER(-)) than for ER(+) tumors (eg, β-carotene: ER(-): top vs bottom quintile RR = 0.52, 95% CI = 0.36 to 0.77, P(trend) = .001; ER(+): RR = 0.83, 95% CI = 0.66 to 1.04, P(trend) = .06; P(heterogeneity) = .01).
Conclusions: This comprehensive prospective analysis suggests women with higher circulating levels of α-carotene, β-carotene, lutein+zeaxanthin, lycopene, and total carotenoids may be at reduced risk of breast cancer.
Figures
Similar articles
-
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.Am J Clin Nutr. 2012 Mar;95(3):713-25. doi: 10.3945/ajcn.111.014415. Epub 2012 Jan 25. Am J Clin Nutr. 2012. PMID: 22277553 Free PMC article.
-
Plasma carotenoids and risk of breast cancer over 20 y of follow-up.Am J Clin Nutr. 2015 Jun;101(6):1197-205. doi: 10.3945/ajcn.114.105080. Epub 2015 Apr 15. Am J Clin Nutr. 2015. PMID: 25877493 Free PMC article.
-
A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India.J Epidemiol. 1999 Nov;9(5):306-14. doi: 10.2188/jea.9.306. J Epidemiol. 1999. PMID: 10616263
-
Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies.Am J Clin Nutr. 2012 Aug;96(2):356-73. doi: 10.3945/ajcn.112.034165. Epub 2012 Jul 3. Am J Clin Nutr. 2012. PMID: 22760559 Review.
-
Carotenoids and the risk of developing lung cancer: a systematic review.Am J Clin Nutr. 2008 Aug;88(2):372-83. doi: 10.1093/ajcn/88.2.372. Am J Clin Nutr. 2008. PMID: 18689373 Review.
Cited by 51 articles
-
Development and validation of circulating CA125 prediction models in postmenopausal women.J Ovarian Res. 2019 Nov 26;12(1):116. doi: 10.1186/s13048-019-0591-4. J Ovarian Res. 2019. PMID: 31771659 Free PMC article.
-
Urinary PGE-M Levels and Risk of Ovarian Cancer.Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1845-1852. doi: 10.1158/1055-9965.EPI-19-0597. Epub 2019 Aug 6. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31387969 Free PMC article.
-
Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review.In Vivo. 2019 Jul-Aug;33(4):983-997. doi: 10.21873/invivo.11568. In Vivo. 2019. PMID: 31280187 Free PMC article. Review.
-
Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer.Am J Clin Nutr. 2019 May 1;109(5):1393-1401. doi: 10.1093/ajcn/nqy392. Am J Clin Nutr. 2019. PMID: 30968114 Free PMC article.
-
Predicting Circulating CA125 Levels among Healthy Premenopausal Women.Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1076-1085. doi: 10.1158/1055-9965.EPI-18-1120. Epub 2019 Apr 4. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30948451 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
- HL099355/HL/NHLBI NIH HHS/United States
- R01 CA131218/CA/NCI NIH HHS/United States
- HL043851/HL/NHLBI NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- R37 CA70867/CA/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- CA-047988/CA/NCI NIH HHS/United States
- R01 CA106591/CA/NCI NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- P01 CA33619/CA/NCI NIH HHS/United States
- R37 CA54281/CA/NCI NIH HHS/United States
- N02 CP1101066/CP/NCI NIH HHS/United States
- N01 PC35137/PC/NCI NIH HHS/United States
- Intramural NIH HHS/United States
- R03 CA128073/CA/NCI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- N01 PC35139/PC/NCI NIH HHS/United States
- R01 CA098661/CA/NCI NIH HHS/United States
- HL080467/HL/NHLBI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- 5 T32 CA09001-35/CA/NCI NIH HHS/United States
- ES000260/ES/NIEHS NIH HHS/United States
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous